In addition, VEGF is associated with the prognosis of ESCC during concurrent RT, and changes in serum VEGF levels (∆VEGF2) after RT are independent influencing factors on OS and PFS in ESCC patients [129]. This evidence concerns the gene VEGFA and esophageal squamous cell carcinoma.